- Home
- NVNO vs MODD Comparison
NVNO vs MODD Comparison
Compare NVNO & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- MODD
- Stock Information
- Founded
- NVNO 1987
- MODD 1998
- Country
- NVNO United States
- MODD United States
- Employees
- NVNO N/A
- MODD N/A
- Industry
- NVNO Medical/Dental Instruments
- MODD Industrial Specialties
- Sector
- NVNO Health Care
- MODD Health Care
- Exchange
- NVNO Nasdaq
- MODD Nasdaq
- Market Cap
- NVNO 59.4M
- MODD 67.4M
- IPO Year
- NVNO N/A
- MODD N/A
- Fundamental
- Price
- NVNO $3.30
- MODD $1.94
- Analyst Decision
- NVNO
- MODD Buy
- Analyst Count
- NVNO 0
- MODD 1
- Target Price
- NVNO N/A
- MODD $5.00
- AVG Volume (30 Days)
- NVNO 117.4K
- MODD 102.4K
- Earning Date
- NVNO 10-31-2024
- MODD 11-14-2024
- Dividend Yield
- NVNO N/A
- MODD N/A
- EPS Growth
- NVNO N/A
- MODD N/A
- EPS
- NVNO N/A
- MODD N/A
- Revenue
- NVNO N/A
- MODD N/A
- Revenue This Year
- NVNO N/A
- MODD N/A
- Revenue Next Year
- NVNO N/A
- MODD $830.43
- P/E Ratio
- NVNO N/A
- MODD N/A
- Revenue Growth
- NVNO N/A
- MODD N/A
- 52 Week Low
- NVNO $3.01
- MODD $1.07
- 52 Week High
- NVNO $6.97
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- NVNO 43.55
- MODD 30.85
- Support Level
- NVNO $3.24
- MODD $2.00
- Resistance Level
- NVNO $3.75
- MODD $2.20
- Average True Range (ATR)
- NVNO 0.18
- MODD 0.14
- MACD
- NVNO 0.02
- MODD -0.03
- Stochastic Oscillator
- NVNO 12.62
- MODD 17.31
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.